Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency

NEXT STORY
Galectin Therapeutics’ Phase 2 NASH Cirrhosis Clinical Trial Results on Belapectin (GR-MD-02) Published in Gastroenterology
PREV STORY
James E. Wagner Cultivation Corporation Expands Compassionate Care Program and Announces New Strains
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Esperite NV (ESP) with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the first-in-man clinical trials in treatment of Crohn’s disease.

Amsterdam, The Netherlands -17th May 2018 Esperite's The Cell Factory has signed today the agreement with ...

author_avatar
NASDAQ Market News

Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results

author_avatar
NASDAQ Market News

Iterum Therapeutics Announces Revised Results of Rights Offering

author_avatar
NASDAQ Market News